RE: DERAMPERS1 Mar 2021 10:08
Paraytec's team has demonstrated that its patented capture and detection technology platform works with a range of aptamers and proteins. With this knowledge, the platform will be developed to test for new viruses and variants of COVID-19. Importantly, the Paraytec team is also exploring its use for rapid detection and identification of bacterial and viral pathogens present in patients with sepsis, a global killer of over 11 million people per year.